Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Recher

Showing results (351-360 of 488) with videos related to

Pageof 49
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2022
Impact of FLT3 Mutation on Outcomes after Venetoclax and Azacitidine for Patients with Treatment-Naïve Acute Myeloid LeukemiaMarina Konopleva, Michael J Thirman, Keith W Pratz, et al.
Clinical Immunology (Orlando, Fla.)|January 3, 2013
Intronic SH2D1A mutation with impaired SAP expression and agammaglobulinemiaMike Recher, Ari J Fried, Michel J Massaad, et al.
Hemasphere|February 14, 2025
HLA evolutionary divergence score after donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantationSophie Le Grand, Juliette Villemonteix, Etienne Daguindau, et al.
Cell Death & Disease|November 4, 2016
CD169<sup>+</sup> macrophages regulate PD-L1 expression via type I interferon and thereby prevent severe immunopathology after LCMV infectionNamir Shaabani, Vikas Duhan, Vishal Khairnar, et al.
Frontiers in Immunology|January 7, 2021
Co-Occurrence of ANCA-Associated Vasculitis and Sjögren's Syndrome in a Patient With Acromegaly: A Case Report and Retrospective Single-Center Review of Acromegaly PatientsPhilipp S Fuchs, Jonas Lötscher, Caroline M Berkemeier, et al.
Haematologica|December 31, 2016
Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the <i>Groupe Francophone Des Myélodysplasies</i>Lionel Ades, Thomas Prebet, Aspasia Stamatoullas, et al.
Nature Medicine|January 18, 2005
Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune diseaseKarl S Lang, Mike Recher, Tobias Junt, et al.
Blood|June 4, 2016
Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapyRuxanda Moschoi, Véronique Imbert, Marielle Nebout, et al.
The Lancet. Haematology|April 12, 2016
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 studyCéline Berthon, Emmanuel Raffoux, Xavier Thomas, et al.
Pediatric Nephrology (Berlin, Germany)|March 14, 2022
Cardiac involvement in pediatric hemolytic uremic syndromeCorentin Tanné, Etienne Javouhey, Olivia Boyer, et al.
Pageof 49

Showing results (351-360 of 488) with videos related to

Sort By:
Pageof 49
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2022
Impact of FLT3 Mutation on Outcomes after Venetoclax and Azacitidine for Patients with Treatment-Naïve Acute Myeloid LeukemiaMarina Konopleva, Michael J Thirman, Keith W Pratz, et al.
Clinical Immunology (Orlando, Fla.)|January 3, 2013
Intronic SH2D1A mutation with impaired SAP expression and agammaglobulinemiaMike Recher, Ari J Fried, Michel J Massaad, et al.
Hemasphere|February 14, 2025
HLA evolutionary divergence score after donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantationSophie Le Grand, Juliette Villemonteix, Etienne Daguindau, et al.
Cell Death & Disease|November 4, 2016
CD169<sup>+</sup> macrophages regulate PD-L1 expression via type I interferon and thereby prevent severe immunopathology after LCMV infectionNamir Shaabani, Vikas Duhan, Vishal Khairnar, et al.
Frontiers in Immunology|January 7, 2021
Co-Occurrence of ANCA-Associated Vasculitis and Sjögren's Syndrome in a Patient With Acromegaly: A Case Report and Retrospective Single-Center Review of Acromegaly PatientsPhilipp S Fuchs, Jonas Lötscher, Caroline M Berkemeier, et al.
Haematologica|December 31, 2016
Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the <i>Groupe Francophone Des Myélodysplasies</i>Lionel Ades, Thomas Prebet, Aspasia Stamatoullas, et al.
Nature Medicine|January 18, 2005
Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune diseaseKarl S Lang, Mike Recher, Tobias Junt, et al.
Blood|June 4, 2016
Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapyRuxanda Moschoi, Véronique Imbert, Marielle Nebout, et al.
The Lancet. Haematology|April 12, 2016
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 studyCéline Berthon, Emmanuel Raffoux, Xavier Thomas, et al.
Pediatric Nephrology (Berlin, Germany)|March 14, 2022
Cardiac involvement in pediatric hemolytic uremic syndromeCorentin Tanné, Etienne Javouhey, Olivia Boyer, et al.
Pageof 49